Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide Descriptor: 2-[(4-fluorophenyl)sulfonyl-(2-
AUC values for predicting drug-target interactions are shown to compare two cases of using experimentally validated interactions and by using all interactions including experiments, text mining, and o
